Safety, Tolerability And Efficacy Of Volixibat, An Apical Sodium-Dependent Bile Acid Transporter Inhibitor, In Adults With Non-Alcoholic Steatohepatitis: 24-Week Interim Analysis Results From A Phase 2 Study
JOURNAL OF HEPATOLOGY（2019）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要